Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 4 résultats.
    • Article de périodique
    Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
    Gold, Ralf Kappos, Ludwig Arnold, Douglas L Bar-Or, Amit Giovannoni, Gavin Selmaj, Krzysztof Tornatore, Carlo Sweetser, Marianne T Yang, Minhua Sheikh, Sarah I Dawson, Katherine T Sindic, Christian[UCL] (2012) New England Journal of Medicine — Vol. 367, no.12, p. 1098-107 (2012)
    • Article de périodique
    Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.
    Polman, Chris Kappos, Ludwig Freedman, Mark S Edan, Gilles Hartung, Hans-Peter Miller, David H Montalbán, Xavier Barkhof, Frederick Selmaj, Krzysztof Uitdehaag, Bernard M J Dahms, Susanne Bauer, Lars Pohl, Christoph Sandbrink, Rupert Sindic, Christian[UCL] (2008) Journal of neurology — Vol. 255, no.4, p. 480-7 (2008)
    • Article de périodique
    Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
    Hauser, Stephen L Bar-Or, Amit Comi, Giancarlo Giovannoni, Gavin Hartung, Hans-Peter Hemmer, Bernhard Lublin, Fred Montalban, Xavier Rammohan, Kottil W Selmaj, Krzysztof Traboulsee, Anthony Wolinsky, Jerry S Arnold, Douglas L Klingelschmitt, Gaelle Masterman, Donna Fontoura, Paulo Belachew, Shibeshih Chin, Peter Mairon, Nicole Garren, Hideki Kappos, Ludwig OPERA I and OPERA II Clinical Investigators Van Pesch, Vincent[UCL] (2017) New England Journal of Medicine — Vol. 376, no. 3, p. 221-234 (2017)
    • Article de périodique
    Ofatumumab versus Teriflunomide in Multiple Sclerosis.
    Hauser, Stephen L Bar-Or, Amit Cohen, Jeffrey A Comi, Giancarlo Correale, Jorge Coyle, Patricia K Cross, Anne H de Seze, Jerome Leppert, David Montalban, Xavier Selmaj, Krzysztof Wiendl, Heinz Kerloeguen, Cecile Willi, Roman Li, Bingbing Kakarieka, Algirdas Tomic, Davorka Goodyear, Alexandra Pingili, Ratnakar Häring, Dieter A Ramanathan, Krishnan Merschhemke, Martin Kappos, Ludwig ASCLEPIOS I and ASCLEPIOS II Trial Groups Van Pesch, Vincent[UCL] (2020) The New England journal of medicine — Vol. 383, no. 6, p. 546-557 (2020)